Evidence map›Paper›PMID 32985792›Full record

ArticleAngewandte Chemie (International ed. in English)2021

En Route Towards the Control of Luminescent, Optically-Active 3D Architectures.

Philip Hindenberg, Frank Rominger, Carlos Romero-Nieto

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Synthesis, Post-Functionalization and Properties of Diphosphapentaarenes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  5. En Route Towards the Control of Luminescent, Optically-Active 3D Architectures.Angewandte Chemie (International ed. in English) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philip HindenbergRuprecht-Karls-Universität Heidelberg, Organisch-Chemisches Institut, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany.
Frank RomingerRuprecht-Karls-Universität Heidelberg, Organisch-Chemisches Institut, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany.
Carlos Romero-NietoRuprecht-Karls-Universität Heidelberg, Organisch-Chemisches Institut, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-3472-933X

Funding

Deutsche Forschungsgemeinschaft RO4899/4-1Junta de Comunidades de Castilla-La Mancha SBPLY/17/180501/000518Ministerio de Ciencia, Innovación y Universidades RTI2018-101865-A-I00
6 · The paper itself

Abstract

π-Extended systems are key components for the development of future organic electronic technologies. While conceiving molecules with improved properties is fundamental for the evolution of materials science, keeping control over the 3D arrangement of molecules represents an ever-expanding challenge. Herein, a synthetic protocol to replace carbon atoms of π-systems by dissymmetric phosphorus atoms is reported; in particular, it allowed for conceiving new fused phosphapyrene derivatives with improved properties. The presence of dissymmetric phosphorus atoms precluded the formation of excimers. X-ray diffraction revealed that, meanwhile, strong intermolecular interactions are taking place in the solid state. The phosphapyrenes photoluminesce in the visible region with high quantum yields; importantly, they are CD-active. In addition, the unique non-planar features of phosphorus atoms allowed for the control of the 3D arrangement of molecules, rendering lemniscate-like structures. Based on our discoveries, we envisage the possibility to construct higher-order, chiral 3D architectures from larger phosphorus-containing π-systems.

Indexed as

3D molecular arrangementMain group chemistryoptical propertiesorganophosphorus materialsphosphorus heterocycles

Identifiers

PMID32985792
PMCPMC7820950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.